Access Infinity

View organization page for Access Infinity

LONDON, UK – Tuesday 24th February 2026 – Access Infinity, a global market access partner combining innovative technology and expert consulting solutions, today announced it has secured an investment from CBPE Capital (“CBPE”) to accelerate its next phase of growth.   

CBPE has a strong track record of supporting ambitious, high-growth businesses in the healthcare and technology sectors. Its investment in Access Infinity reflects CBPE’s confidence in the company’s leadership team, differentiated platform and long-term growth potential.

The partnership will enable Access Infinity to further enhance its technology platform and accelerate international expansion. It will also support continued investment in talent, innovation, and client services, building on a customer base that already includes 22 of the world’s top 25 pharmaceutical companies.

Founded in 2014, Access Infinity has established itself as a trusted partner for life sciences companies worldwide, providing a suite of software and consulting services that support clients throughout the drug development lifecycle. The company’s innovative software solutions (comprising Access HubTM, Evidence HubTM and NuroTM) and expert consulting team help pharma clients navigate complex global market access challenges, optimise pricing strategies, and deliver value to patients across diverse healthcare systems.

Shrinivas Rao Mukku and Ahmed Edathodu, Founding Directors of Access Infinity, commented: “We are delighted to partner with CBPE for the next stage of our journey. Their experience and support will be invaluable as we continue to grow our business, invest in our people, and deliver exceptional value to our clients.”

Naveen Passi, Partner at CBPE, added: “We have been hugely impressed by Access Infinity’s expertise, innovation, and client-centric approach. We are excited to be working closely with the team to help realise their exciting plans for growth and continued leadership in the market access space.”

Terms of the transaction were not disclosed.

Source: | 05-03-2026